PLXND1 and neoplasm: We demonstrated that PlexinD1 is transcriptionally suppressed by AR via direct AR interaction with PLXND1 promoter, which is a likely mechanism for the upregulation of PlexinD1 observed in PCa tumor clinical samples post-hormone therapy as well as in AR-negative CRPC and NEPC cells.